» Articles » PMID: 34094023

An Updated Systematic Review and Meta-analysis on Antibiotic Resistance in Iran (2013-2020)

Overview
Specialty General Medicine
Date 2021 Jun 7
PMID 34094023
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

This updated systematic review and meta-analysis follows two aims: 1) to assess antibiotic resistance in Iran from 2013 to 2020 and, 2) to assess the trend of resistance from 1999 to 2020. Several national and international databases were systematically searched through MeSH extracted keywords to identify 41 published studies addressing drug-resistant in Iran. Meta-analysis was done based on the PRISMA protocols using Comprehensive Meta-Analysis software. The average prevalence of resistance to first- and second-line anti-TB drugs, multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) in new and previously treated tuberculosis (TB) cases in Iran during 2013-2020 were as follows: isoniazid 6.9%, rifampin 7.9%, ethambutol 5.7%, pyrazinamide 20.4%, -aminosalicylic acid 4.6%, capreomycin 1.7%, cycloserine 1.8%, ethionamide 11.3%, ofloxacin 1.5%, kanamycin 3.8%, amikacin 2.2%, MDR-TB 6.3% and XDR-TB 0.9%. Based on the presented data, resistance to first- and second-line anti-TB drugs, as well as MDR-TB, was low during 2013-2020 in Iran. Furthermore, there was a declining trend in TB drug resistance from 1999 to 2020. Hence, to maintain the current decreasing trend and to control and eliminate TB infection in Iran, continuous monitoring of resistance patterns is recommended.

Citing Articles

Drug resistance and genomic variations among Mycobacterium tuberculosis isolates from The Nile Delta, Egypt.

Soliman M, Hansen C, Hanafy M, Shawky S, Rashed H, Abdullah M Sci Rep. 2024; 14(1):20401.

PMID: 39223176 PMC: 11369133. DOI: 10.1038/s41598-024-70199-8.


Bayesian estimation of the time-varying reproduction number for pulmonary tuberculosis in Iran: A registry-based study from 2018 to 2022 using new smear-positive cases.

Rastegar M, Nazar E, Nasehi M, Sharafi S, Fakoor V, Shakeri M Infect Dis Model. 2024; 9(3):963-974.

PMID: 38873589 PMC: 11169078. DOI: 10.1016/j.idm.2024.05.003.


Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran: Systematic review and meta-analysis.

Abbasian S, Heidari H, Tadi D, Kardan-Yamchi J, Taji A, Darbandi A J Clin Tuberc Other Mycobact Dis. 2024; 35:100430.

PMID: 38560029 PMC: 10981085. DOI: 10.1016/j.jctube.2024.100430.


Factors Associated with Non-Adherence to Treatment Among Migrants with MDR-TB in Wuhan, China: A Cross-Sectional Study.

Lin K, Xiang L Risk Manag Healthc Policy. 2024; 17:727-737.

PMID: 38559871 PMC: 10981374. DOI: 10.2147/RMHP.S448706.


Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis.

Hosseinali Z, Mohammadshahi J, Teimourpour A, Habibzadeh S, Esmaelizad M, Arzanlou M Mol Biol Rep. 2023; 50(12):10271-10275.

PMID: 37971566 DOI: 10.1007/s11033-023-08867-7.


References
1.
Pooideh M, Jabbarzadeh I, Ranjbar R, Saifi M . Molecular Epidemiology of Mycobacterium tuberculosis Isolates in 100 Patients With Tuberculosis Using Pulsed Field Gel Electrophoresis. Jundishapur J Microbiol. 2015; 8(7):e18274. PMC: 4575773. DOI: 10.5812/jjm.8(5)2015.18274. View

2.
Khademi F, Yousefi A, Derakhshan M, Najafi A, Tafaghodi M . Enhancing immunogenicity of novel multistage subunit vaccine of using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration. Iran J Basic Med Sci. 2019; 22(8):893-900. PMC: 6760476. DOI: 10.22038/ijbms.2019.33962.8079. View

3.
Mansoori N, Yaseri M, Vaziri F, Douraghi M . Genetic diversity of Mycobacterium tuberculosis complex isolates circulating in an area with high tuberculosis incidence: Using 24-locus MIRU-VNTR method. Tuberculosis (Edinb). 2018; 112:89-97. DOI: 10.1016/j.tube.2018.08.003. View

4.
Khanipour S, Ebrahimzadeh N, Masoumi M, Sakhaei F, Alinezhad F, Safarpour E . Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey. J Glob Antimicrob Resist. 2016; 5:7-10. DOI: 10.1016/j.jgar.2016.01.007. View

5.
Karimi S, Mirhendi H, Zaniani F, Manesh S, Salehi M, Esfahani B . Rapid Detection of Streptomycin-Resistant by -Restriction Fragment Length Polymorphism. Adv Biomed Res. 2017; 6:126. PMC: 5672647. DOI: 10.4103/abr.abr_240_16. View